ZyVersa Therapeutics, Inc.(NASDAQ:ZVSA) 
ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and...
Website: https://www.zyversa.com
Founded: 2014
Full Time Employees: 6
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.67
H 0.67
L 0.59
C 0.62
V 32,205
10EMA 0.62
20EMA 0.62
60EMA 0.62
120EMA 0.62
250EMA 0.62